Drug Information - A Guide for Pharmacists / Edition 4

Paperback (Print)
Rent
Rent from BN.com
$11.12
(Save 83%)
Est. Return Date: 06/15/2014
Buy Used
Buy Used from BN.com
$43.21
(Save 35%)
Item is in good condition but packaging may have signs of shelf wear/aging or torn packaging.
Condition: Used – Good details
Used and New from Other Sellers
Used and New from Other Sellers
from $1.99
Usually ships in 1-2 business days
(Save 97%)
Other sellers (Paperback)
  • All (20) from $1.99   
  • New (8) from $43.63   
  • Used (12) from $1.99   

Overview

Everything pharmacists need to know about drug information management

Drug Information: A Guide for Pharmacists, Fourth Edition teaches students and professionals how to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible. Updated throughout, the book also addresses other important issues such as the legal and ethical considerations of providing information, how to respond to requests for information, and how to determine what information should be made available.

Drug Information: A Guide for Pharmacists, Fourth Edition covers essential topics such as:

  • Formulating effective responses and recommendations for information
  • Evaluation of drug literature
  • The application of statistical analysis in the biomedical sciences
  • Drug evaluation monographs
  • Adverse drug reactions
  • Medication and patient safety
  • Investigational drugs

New to this edition:

  • Five new chapters: “Policy Development, Project Design, and Implementation,” “Drug Information in Ambulatory Care,” “Drug Information and Contemporary Community Pharmacy Practice,” “Drug Information Education and Training,” and “Pharmaceutical Industry and Regulatory Affairs: Opportunities for Drug Information Specialists”
  • Key Concepts have been added to the beginning of each chapter and are identified with icons in the chapter text
  • Case Studies and multiple-choice questions have been added to most chapters

Twenty-two appendices include: Drug Consultation Request Form,

Performing a PubMed® Search, Questions for Assessing Clinical Trials, and

Questions to Consider for Critique of Primary Literature.

Read More Show Less

Editorial Reviews

From The Critics
Reviewer: Anna Wodlinger Jackson, PharmD (Inova Fairfax Hospital)
Description: This book reviews all aspects of providing drug information, extensively discussing every pertinent issue that should be addressed. This is an update of a 2006 edition.
Purpose: The purpose is to provide training in information management. This edition has been expanded to include additional material for educating both students and practitioners on how to research, interpret, evaluate, collate, and disseminate information. These are worthy objectives, as the need for effective drug information practices is critical. The authors provide extensive reviews and have added chapters to meet the objectives.
Audience: The book targets students and practitioners training in information management. This is a relevant tool for all students, but particularly for pharmacy residents and practitioners who may be performing drug information activities. It is particularly helpful for individuals who may not have had extensive training in drug information. The authors include practitioners from all areas of practice and numerous institutions.
Features: The book covers many of the basic components pertinent to drug information activities (answering drug information questions, formulary management) but also includes chapters that thoroughly review literature evaluation, professional writing, medication errors, and adverse drug reactions. This edition also includes information on legal considerations and new areas of focus (ambulatory care, community pharmacy practice, industry). The best features of the book are the highlighted key points throughout the chapters and the case studies, which are new to this edition. An extensive glossary and appendixes provide more information and examples.
Assessment: This is a high-quality guide to various aspects of drug information and information management. It has evolved with the changing needs of healthcare and information technology and provides a thorough review useful for anyone practicing and providing drug information. This edition includes chapters that address the changing needs in drug information. There are other drug information books (Contemporary Drug Information: An Evidence-Based Approach, Gaebelein and Gleason (Lippincott Williams & Wilkins, 2008); Drug Information: A Guide to Current Resources, 3rd edition, Snow (Neal-Schuman Publishers, 2008)) but they do not include as comprehensive a review as this book does.
Read More Show Less

Product Details

  • ISBN-13: 9780071624954
  • Publisher: McGraw-Hill Professional Publishing
  • Publication date: 8/17/2011
  • Edition description: New Edition
  • Edition number: 4
  • Pages: 1192
  • Sales rank: 881,019
  • Product dimensions: 5.90 (w) x 8.90 (h) x 1.70 (d)

Meet the Author

Author Profiles

Patrick M. Malone, PharmD, FASHP

The University of Findlay

School of Pharmacy

Findlay, Ohio

Karen L. Kier, PhD, MSc, RPh

Ohio Northern University

College of Pharmacy

Ada, Ohio

John E. Stanovich, RPh

Ohio Northern University

College of Pharmacy

Ada, Ohio

Read More Show Less

Table of Contents

Chapter One. Introduction to the Concept of Medication Information
Mary Lea Gora-Harper and J. Russell May
Chapter Two. Formulating Effective Responses and Recommendations: A Structured Approach
Karim Anton Calis and Amy Heck Sheehan
Chapter Three. Drug Information Resources
Kelly M. Shields and Elaine Blythe
Chapter Four. Literature Evaluation I: Controlled Clinical Trial Evaluation
Michael Kendrach, Maisha Kelly Freeman, Terri M. Wensel, and Peter J. Hughes
Chapter Five. Literature Evaluation II: Beyond the Basics
Patrick J. Bryant, Karen P. Norris, Cydney E. McQueen, and Elizabeth A. Poole
Chapter Six. Pharmacoeconomics
James P. Wilson and Karen L. Rascati
Chapter Seven. Evidence-Based Clinical Practice Guidelines
Kevin G. Moores
Chapter Eight. The Application of Statistical Analysis in the Biomedical Sciences
Ryan W. Walters and Karen L. Kier
Chapter Nine. Professional Writing
Patrick M. Malone
Chapter Ten. Legal Aspects of Drug Information Practice
Martha M. Rumore
Chapter Eleven. Ethical Aspects of Drug Information Practice
Linda K. Ohri
Chapter Twelve. Pharmacy and Therapeutics Committee
Patrick M. Malone, Nancy L. Fagan, Mark A. Malesker, and Paul J. Nelson
Chapter Thirteen. Drug Evaluation Monographs
Patrick M. Malone, Nancy L. Fagan, Mark A. Malesker, Paul J. Nelson, and Linda K. Ohri
Chapter Fourteen. Quality Improvement and the Medication Use Process
Mark A. Ninno and Sharon Davis Ninno
Chapter Fifteen. Medication Misadventures I: Adverse Drug Reactions
Philip J. Gregory and Zara Risoldi Cochrane
Chapter Sixteen. Medication Misadventures II: Medication and Patient Safety
Kathryn A. Crea
Chapter Seventeen. Investigational Drugs
Bambi Grilley
Chapter Eighteen. Policy Development, Project Design, and Implementation
Stacie Krick Evans
Chapter Nineteen. Drug Information in Ambulatory Care
Debra L. Parker
Chapter Twenty. Drug Information and Contemporary Community Pharmacy Practice
Morgan L. Sperry and Patricia A. Marken
Chapter Twenty-One. Drug Information Education and Training
Kelly M. Smith
Chapter Twenty-Two. Pharmaceutical Industry and Regulatory Affairs: Opportunities for Drug Information Specialists
Jean E. Cunningham and Lindsay E. Davison
Appendix 2-1. Drug Consultation Request Form
Appendix 2-2. Sample Questions for Obtaining Background Information From Requestors
Appendix 3-1. Performing a PubMed Search
Appendix 3-2. Selected Primary Literatures Sources
Appendix 4-1. Questions for Assessing Clinical Trials
Appendix 5-1. Beyond the Basics: Questions to Consider for Critique of Primary Literature
Appendix 7-1. New Zealand Guidelines Group (NZGG)
Appendix 7-2. National Institute for Clinical Excellence (NICE)
Appendix 7-3. National Institute for Clinical Excellence (NICE) Topic Selection Criteria
Appendix 7-4. Study Selection Process—Centre for Reviews and Dissemination (CRD)
Appendix 7-5. Study Selection Points—Centre for Reviews and Dissemination (CRD)
Appendix 7-6. Data Synthesis—Centre for Reviews and Dissemination (CRD)Appendix 7-7. National Institute for Clinical Excellence (NICE)—Evidence Table Format for Intervention Studies
Appendix 7-8. New Zealand Guidelines Group (NZGG)—Considered Judgment
Appendix 7-9. Guidelines Advisory Committee (GAC) —Levels of Evidence Grades of Recommendation
Appendix 7-10. National Institute for Clinical Excellence (NICE) Guideline Structure
Appendix 7-11. Scottish Intercollegiate Guidelines Network (SIGN) Consultation and Peer-Review
Appendix 7-12. Grades of Recommendation Assessment Development and Evaluation (GRADE) System Advantages
Appendix 7-13. Appraisal of Guidelines Research & Evaluation (AGREE) Instrument
Appendix 7-14. Conference on Guideline Standardization (COGS) Checklist
Appendix 7-15. Implementation Strategies
Appendix 9-1. Question Example
Appendix 9-2. Abstracts
Appendix 9-3. Bibliography
Appendix 11-1. Code of Ethics for Pharmacists
Appendix 12-1. Pharmacy and Therapeutics Committee Procedure
Appendix 12-2. Formulary Request Form
Appendix 12-3. P&T Committee Meeting Attributes
Appendix 12-4. Example P&T Committee Minutes
Appendix 12-5. Chairperson Skills
Appendix 12-6. Conflict-of-Interest Declaration
Appendix 13-1. Format for Drug Monograph
Appendix 13-2. Example Drug Monograph
Appendix 14-1. Comparison of Quality Assurance and Total Quality Management in Health Care
Appendix 14-2. Tools Used in Quality Improvement
Appendix 14-3. Examples of Approaches to Quality Improvement
Appendix 14-4. Example of a Quality Improvement Activity Plan
Appendix 14-5. Example Report—Prescriber-Specific Results
Appendix 14-6. Example of MUE Results
Appendix 14-7. Quality Evaluation: Response to Drug Information Request
Appendix 15-1. Kramer Questionnaire
Appendix 15-2. Naranjo Algorithm
Appendix 15-3. Jones Algorithm
Appendix 15-4. MedWatch Form
Appendix 17-1. Investigational New Drug Application
Appendix 17-2. Statement of Investigator
Appendix 17-3. Protocol Medication Economic Analysis
Appendix 17-4. Investigational Drug Accountability Record
Appendix 18-1. High-Alert Medications
Appendix 18-2. Medication Shortages and Backorders
Appendix 19-1. FDA Guidelines for Proper Medication Disposal
Appendix 22-1. Response Letter: Drug A—Incidence of Yellow Stripes
Glossary
Answers for Case Studies
Answers for Self-Assessment Questions
Index
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Anonymous

    Posted November 13, 2011

    No text was provided for this review.

Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)